{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:42Z","timestamp":1788322662828,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T00:00:00Z","timestamp":1463097600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"cellbiotech"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00535-016-1224-y","type":"journal-article","created":{"date-parts":[[2016,5,13]],"date-time":"2016-05-13T05:50:32Z","timestamp":1463118632000},"page":"432-443","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial"],"prefix":"10.1007","volume":"52","author":[{"given":"Kyungsun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghwa","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Gu","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hojun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,13]]},"reference":[{"issue":"3","key":"1224_CR1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","volume":"119","author":"IM Gralnek","year":"2000","unstructured":"Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119(3):654\u201360.","journal-title":"Gastroenterology"},{"issue":"1","key":"1224_CR2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00535-014-1017-0","volume":"50","author":"S Fukudo","year":"2015","unstructured":"Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50(1):11\u201330.","journal-title":"J Gastroenterol"},{"issue":"3","key":"1224_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nrgastro.2010.4","volume":"7","author":"L \u00d6hman","year":"2010","unstructured":"\u00d6hman L, Simr\u00e9n M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol. 2010;7(3):163\u201373.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"1224_CR4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.amjmed.2015.01.036","volume":"128","author":"GS Sayuk","year":"2015","unstructured":"Sayuk GS, Gyawali CP. Irritable bowel syndrome: modern concepts and management options. Am J Med. 2015;128(8):817\u201327.","journal-title":"Am J Med."},{"issue":"9135","key":"1224_CR5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(98)02146-1","volume":"352","author":"T King","year":"1998","unstructured":"King T, Elia M, Hunter J. Abnormal colonic fermentation in irritable bowel syndrome. The Lancet. 1998;352(9135):1187\u20139.","journal-title":"The Lancet"},{"issue":"2","key":"1224_CR6","first-page":"96","volume":"79","author":"M Schmulson","year":"2014","unstructured":"Schmulson M, Bielsa MV, Carmona-S\u00e1nchez R, et al. Microbiota, gastrointestinal infections, low-grade inflammation, and antibiotic therapy in irritable bowel syndrome (IBS): an evidence-based review. Rev de Gastroenterol de M\u00e9x. 2014;79(2):96\u2013134 (English edition).","journal-title":"Rev de Gastroenterol de M\u00e9x"},{"issue":"27","key":"1224_CR7","first-page":"8886","volume":"20","author":"KN Lee","year":"2014","unstructured":"Lee KN, Lee OY. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome. World J Gastroenterol: WJG. 2014;20(27):8886.","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"1224_CR8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.gastro.2007.04.005","volume":"133","author":"A Kassinen","year":"2007","unstructured":"Kassinen A, Krogius-Kurikka L, M\u00e4kivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133(1):24\u201333.","journal-title":"Gastroenterology"},{"issue":"2","key":"1224_CR9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","volume":"100","author":"E Malinen","year":"2005","unstructured":"Malinen E, Rinttil\u00e4 T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100(2):373\u201382.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1224_CR10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.2008.167270","volume":"59","author":"P Moayyedi","year":"2010","unstructured":"Moayyedi P, Ford AC, Talley NJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut. 2010;59(3):325\u201332.","journal-title":"Gut"},{"issue":"2","key":"1224_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/09168451.2014.972331","volume":"79","author":"K Minamida","year":"2015","unstructured":"Minamida K, Nishimura M, Miwa K, et al. Effects of dietary fiber with Bacillus coagulans lilac-01 on bowel movement and fecal properties of healthy volunteers with a tendency for constipation. Biosci Biotechnol Biochem. 2015;79(2):300\u20136.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"1224_CR12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2036.2007.03542.x","volume":"27","author":"K Kajander","year":"2008","unstructured":"Kajander K, Myllyluoma E, Rajili\u0107-Stojanovi\u0107 M, et al. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther. 2008;27(1):48\u201357.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"1224_CR13","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"RB Sartor","year":"2004","unstructured":"Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology. 2004;126(6):1620\u201333.","journal-title":"Gastroenterology"},{"issue":"3","key":"1224_CR14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","volume":"121","author":"K Madsen","year":"2001","unstructured":"Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121(3):580\u201391.","journal-title":"Gastroenterology"},{"issue":"4","key":"1224_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jfoodeng.2010.12.031","volume":"104","author":"J Burgain","year":"2011","unstructured":"Burgain J, Gaiani C, Linder M, et al. Encapsulation of probiotic living cells: from laboratory scale to industrial applications. J Food Eng. 2011;104(4):467\u201383.","journal-title":"J Food Eng"},{"issue":"3","key":"1224_CR16","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.5504\/BBEQ.2011.0052","volume":"25","author":"MK Cha","year":"2011","unstructured":"Cha MK, Chung MJ, Kim JE, et al. Comparison of dual coated (Duolac\u2122) and uncoated lactic acid bacteria from potential probiotics. Biotechnol Biotechnol Equip. 2011;25(3):2489\u201393.","journal-title":"Biotechnol Biotechnol Equip"},{"issue":"3","key":"1224_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7845\/kjm.2013.3042","volume":"49","author":"JY Kang","year":"2013","unstructured":"Kang JY, Lee DK, Park JE, et al. Dual coating improves the survival of proviotic bifidobacterium strains during exposure to simulated gastro-intestinal conditions. Korean J Microbiol. 2013;49(3):275\u201381.","journal-title":"Korean J Microbiol"},{"issue":"7","key":"1224_CR18","first-page":"1","volume":"38","author":"Y Yeun","year":"2014","unstructured":"Yeun Y, Lee J. Effect of a double-coated probiotic formulation on functional constipation in the elderly: a randomized, double blind, controlled study. Arch Pharm Res. 2014;38(7):1\u20136.","journal-title":"Arch Pharm Res."},{"issue":"5","key":"1224_CR19","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1007\/BF02064187","volume":"40","author":"DA Drossman","year":"1995","unstructured":"Drossman DA, Li Z, Toner BB, et al. Functional bowel disorders. Dig Dis Sci. 1995;40(5):986\u201395.","journal-title":"Dig Dis Sci"},{"issue":"9209","key":"1224_CR20","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","volume":"355","author":"M Camilleri","year":"2000","unstructured":"Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000;355(9209):1035\u201340.","journal-title":"Lancet"},{"issue":"6","key":"1224_CR21","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/gut.33.6.818","volume":"33","author":"K Heaton","year":"1992","unstructured":"Heaton K, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut. 1992;33(6):818\u201324.","journal-title":"Gut"},{"issue":"7","key":"1224_CR22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1046\/j.1365-2036.2003.01543.x","volume":"17","author":"HJ Kim","year":"2003","unstructured":"Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL# 3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2003;17(7):895\u2013904.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"1224_CR23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Carbin MG. Psychometric properties of the beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8(1):77\u2013100.","journal-title":"Clin Psychol Rev"},{"issue":"2","key":"1224_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/gut.2006.100594","volume":"56","author":"M Guilarte","year":"2007","unstructured":"Guilarte M, Santos J, De Torres I, et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56(2):203\u20139.","journal-title":"Gut"},{"issue":"3","key":"1224_CR25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF03343838","volume":"24","author":"F Patacchioli","year":"2001","unstructured":"Patacchioli F, Angelucci L, Dell\u2019Erba G, et al. Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS). J Endocrinol Invest. 2001;24(3):173\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1224_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-6-26","volume":"6","author":"JA Cole","year":"2006","unstructured":"Cole JA, Rothman KJ, Cabral HJ, et al. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6(1):26.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1224_CR27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF01186280","volume":"11","author":"PC Kendall","year":"1987","unstructured":"Kendall PC, Hollon SD, Beck AT, et al. Issues and recommendations regarding use of the beck depression inventory. Cogn Ther Res. 1987;11(3):289\u201399.","journal-title":"Cogn Ther Res"},{"issue":"6","key":"1224_CR28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MCG.0b013e31820ca4d6","volume":"45","author":"Y Ringel","year":"2011","unstructured":"Ringel Y, Ringel-Kulka T, Maier D, et al. Clinical trial: probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the symptoms of bloating in patients with functional bowel disorders\u2014a double-blind study. J Clin Gastroenterol. 2011;45(6):518.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"1224_CR29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00384-012-1552-1","volume":"28","author":"C Cappello","year":"2013","unstructured":"Cappello C, Tremolaterra F, Pascariello A, et al. A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life. Int J Colorectal Dis. 2013;28(3):349\u201358.","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"1224_CR30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s10620-014-3299-8","volume":"60","author":"RK Wong","year":"2015","unstructured":"Wong RK, Yang C, Song GH, et al. Melatonin regulation as a possible mechanism for probiotic (VSL# 3) in irritable bowel syndrome: a randomized double-blinded placebo study. Dig Dis Sci. 2015;60(1):186\u201394.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"1224_CR31","first-page":"55","volume":"10","author":"S Kim","year":"2015","unstructured":"Kim S, Oh WY, Seung H, et al. Guideline for the clinical evaluation of drugs for the treatment of irritable bowel syndrome. Regul Res Food, Drug Cosmet. 2015;10(1):55\u201362.","journal-title":"Regul Res Food, Drug Cosmet"},{"key":"1224_CR32","unstructured":"FDA. Guidance for industry irritable bowel syndrome\u2014clinical evaluation of drugs for treatment. US Department of Health and Human Sevices Food and Drug Administration Center for Drug Evaluation and Research. 2012."},{"issue":"3","key":"1224_CR33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2982.2010.01664.x","volume":"23","author":"JF Cryan","year":"2011","unstructured":"Cryan JF, O\u2019Mahony S. The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motil. 2011;23(3):187\u201392.","journal-title":"Neurogastroenterol Motil"},{"issue":"05","key":"1224_CR34","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1017\/S0007114510004319","volume":"105","author":"M Messaoudi","year":"2011","unstructured":"Messaoudi M, Lalonde R, Violle N, et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr. 2011;105(05):755\u201364.","journal-title":"Br J Nutr"},{"issue":"2","key":"1224_CR35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jpsychires.2008.03.009","volume":"43","author":"L Desbonnet","year":"2008","unstructured":"Desbonnet L, Garrett L, Clarke G, et al. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43(2):164\u201374.","journal-title":"J Psychiatr Res"},{"issue":"3","key":"1224_CR36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2004.11.050","volume":"128","author":"L O\u2019Mahony","year":"2005","unstructured":"O\u2019Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005;128(3):541\u201351.","journal-title":"Gastroenterology"},{"issue":"5","key":"1224_CR37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/JB.187.5.1543-1551.2005","volume":"187","author":"Jh Rho","year":"2005","unstructured":"Rho Jh, Wright DP, Christie DL, et al. A novel mechanism for desulfation of mucin: identification and cloning of a mucin-desulfating glycosidase (sulfoglycosidase) from Prevotella strain RS2. J Bacteriol. 2005;187(5):1543\u201351.","journal-title":"J Bacteriol"},{"key":"1224_CR38","doi-asserted-by":"crossref","unstructured":"Bergstrom KS, Xia L. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology. 2013:cwt045.","DOI":"10.1093\/glycob\/cwt045"},{"issue":"2","key":"1224_CR39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2036.2010.04328.x","volume":"32","author":"A Ford","year":"2010","unstructured":"Ford A, Moayyedi P. Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome. Aliment Pharmacol Ther. 2010;32(2):144\u201358.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1224_CR40","first-page":"263","volume":"15","author":"K Triantafyllou","year":"2007","unstructured":"Triantafyllou K. Problems and challenges in the design of irritable bowel syndrome clinical trials. Focusing on the future with the experience from the past. Ann Gastroenterol. 2007;15(3):263\u201370.","journal-title":"Ann Gastroenterol."},{"issue":"2","key":"1224_CR41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5056\/jnm.2014.20.2.163","volume":"20","author":"E Shah","year":"2014","unstructured":"Shah E, Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome. J neurogastroenterol Motil. 2014;20(2):163.","journal-title":"J neurogastroenterol Motil"},{"issue":"5","key":"1224_CR42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(99)00086-8","volume":"107","author":"RC Spiller","year":"1999","unstructured":"Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med. 1999;107(5):91\u20137.","journal-title":"Am J Med"},{"issue":"7","key":"1224_CR43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1572-0241.2006.00734.x","volume":"101","author":"PJ Whorwell","year":"2006","unstructured":"Whorwell PJ, Altringer L, Morel J, et al. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. Am J Gastroenterol. 2006;101(7):1581\u201390.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"1224_CR44","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10350-008-9335-z","volume":"51","author":"S Nikfar","year":"2008","unstructured":"Nikfar S, Rahimi R, Rahimi F, et al. Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials. Dis Colon Rectum. 2008;51(12):1775\u201380.","journal-title":"Dis Colon Rectum"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1224-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1224-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1224-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:40:19Z","timestamp":1559083219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1224-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,13]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["1224"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1224-y","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,13]]}}}